The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ryzhko V.V.

FGBU "Gematologicheskiĭ nauchnyĭ tsentr" Ministerstva zdravookhraneniia Rossiĭskoĭ Federatsii, Moskva

Grachev A.E.

Gematologicheskiĭ nauchnyĭ tsentr Minzdrava Rossii, Moskva

Klodzinskiĭ A.A.

Respublikanskiĭ nauchnyĭ tsentr neotlozhnoĭ meditsinskoĭ pomoshchi, Kazakhstan

Ivanova T.V.

Otdelenie ginekologii s primeneniem VRT Tsentral'noĭ klinicheskoĭ bol'nitsy RAN, Moskva

Sataeva M.S.

Respublikanskiĭ nauchnyĭ tsentr neotlozhnoĭ meditsinskoĭ pomoshchi, Kazakhstan

Gribanova E.O.

Hematology Research Center, Ministry of Health of Russia, Moscow, Russia

Myeloproliferative masks of multiple myeloma: A review of literature and clinical case reports

Authors:

Ryzhko V.V., Grachev A.E., Klodzinskiĭ A.A., Ivanova T.V., Sataeva M.S., Gribanova E.O.

More about the authors

Journal: Therapeutic Archive. 2017;89(1): 72‑77

DOI: 10.17116/terarkh201789172-77

Read: 3790 times

Contact the author
Table of contents

MYELOPROLIFERATIVE MASKS OF MULTIPLE MYELOMA: A REVIEW OF LITERATURE AND CLINICAL CASE REPORTS
MYELOPROLIFERATIVE MASKS OF MULTIPLE MYELOMA: A REVIEW OF LITERATURE AND CLINICAL CASE REPORTS

To cite this article:

Ryzhko VV, Grachev AE, Klodzinskiĭ AA, Ivanova TV, Sataeva MS, Gribanova EO. Myeloproliferative masks of multiple myeloma: A review of literature and clinical case reports. Therapeutic Archive. 2017;89(1):72‑77. (In Russ.)
https://doi.org/10.17116/terarkh201789172-77

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Concurrences of multiple myeloma with myeloproliferative diseases or secondary myeloid leukemoid reactions are rather rare. The paper describes 3 cases of multiple myeloma: the first case concurrent with neutrophilic leukocytosis; the second case with secondary erythropoetin-dependent erythrocytosis, and the third case with chronic myeloid leukemia. In such cases, an accurate diagnosis requires molecular testing, besides routine clinical and laboratory studies. The paper discusses therapeutic strategy in cases of a concurrence of 2 competing tumors of the blood system: to treat them simultaneously or the most aggressive tumor now, as well as a relationship between multiple myeloma and chronic myeloid leukemia, other myeloproliferative disorders, and secondary myeloid leukemoid reactions.

Keywords:

multiple myeloma
leukemoid reaction
secondary erythrocytosis
chronic myeloid leukemia

Authors:

Ryzhko V.V.

FGBU "Gematologicheskiĭ nauchnyĭ tsentr" Ministerstva zdravookhraneniia Rossiĭskoĭ Federatsii, Moskva

Grachev A.E.

Gematologicheskiĭ nauchnyĭ tsentr Minzdrava Rossii, Moskva

Klodzinskiĭ A.A.

Respublikanskiĭ nauchnyĭ tsentr neotlozhnoĭ meditsinskoĭ pomoshchi, Kazakhstan

Ivanova T.V.

Otdelenie ginekologii s primeneniem VRT Tsentral'noĭ klinicheskoĭ bol'nitsy RAN, Moskva

Sataeva M.S.

Respublikanskiĭ nauchnyĭ tsentr neotlozhnoĭ meditsinskoĭ pomoshchi, Kazakhstan

Gribanova E.O.

Hematology Research Center, Ministry of Health of Russia, Moscow, Russia

Close metadata

References:

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clinicians. 2014;64(1):9-29.
  2. Alsidawi S, Ghose A, Qualtieri J, Radhakrishnan N. A case of multiple myeloma with metachronous chronic myeloid leukemia treated successfully with bortezomib,dexamethasone, and dasatinib Case. Rep Oncol Med. 2014;2014:962526.
  3. Schwarzmeier JD, Shehata M, Ackermann J, Hilgarth M, Kaufmann H, Drach J. Simultaneous occurrence of chronic myeloid leukemia and multiple myeloma: evaluation by FISH analysis and in vitro expansion of bone marrow cells. Leukemia. 2003;17(7):1426-1428.
  4. Alvarez-Larrán A, Rozman M, Cervantes F. Simultaneous occurrence of multiple myeloma and chronic myeloid leukemia. Haematologica. 2001;86(8):894.
  5. Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, Oizumi K. Coexistence of chronic myelogenous leukemia and multiple myeloma: case report and review of the literature. Acta Haematologica. 1998;99(4):221-223.
  6. Boots MA, Pegrum GD. Simultaneous presentation of chronic granulocytic leukaemia and multiple myeloma. J Clin Pathol. 1982;35(3):364-365.
  7. Offiah C, Murphy PT, Quinn JP, Thornton P. Co-existing chronic myeloid leukaemia and multiple myeloma: rapid response to lenalidomid eduring imatinib treatment. Int J Hematol. 2012;95(4):451-452.
  8. Romanenko NA, Bessmel'tsev SS, Udal'eva VI, Zenina MN, Martynkevich IS, Rugal' VI, Abdulkadyrov KM. The combination of chronic myeloid leukemia and multiple myeloma in one patient. Voprosy Onkologii. 2013;59(2):103-110.
  9. Derghazarian C, Whittemore NB. Multiple myeloma superimposed on chronic myelocytic leukemia. Canadian Med Associa J. 1974;110(9):1047-1050.
  10. Ide M, Kuwahara N, Matsuishi E, Kimura S, Gondo H. Uncommon case of chronic myeloid leukemia with multiple myeloma. Int J Hematol. 2010;91(4):699-704. doi:10.1007/s12185-010-0546-4
  11. Michael M, Antoniades M, Lemesiou E, Papaminas N, Melanthiou F. Development of multiple myeloma in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate for 65 months. Oncologist. 2009;14(12):1198-1200.
  12. Galanopoulos A, Papadhimitriou SI, Kritikou-Griva E, Georgiakaki M, Anagnostopoulos NI. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia. Ann Hematol. 2009;88(3):281-282.
  13. Garipidou V, Vakalopoulou S, Tziomalos K. Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate. Oncologist. 2005;10(6):457-458.
  14. Nitta M, Tsuboi K, Yamashita S, Kato M, Hayami Y, Harada S, Komatsu H, Iida S, Banno S, Wakita A, Ueda R. Multiple myeloma preceding the development of chronic myelogenous leukemia. Int J Hematol. 1999;69(3):170-173.
  15. Klenn PJ, Hyun BH, Lee YH, Zheng WY. Multiple myeloma and chronic myelogenous leukemia: a case report with literature review. Yonsei Med J. 1993;34(3):293-300. doi:10.3349/ymj.1993.34.3.293
  16. Ragupathi L, Najfeld V, Chari A, Petersen B, Jagannath S, Mascarenhas J. A case report of chronic myelogenous leukemiain a patient with multiple myeloma and a review of the literature. Clin Lymphoma Myeloma Leukemia. 2012;13(2):175-179.
  17. Caparrotti G, Esposito D, Graziani F, De FG, Pagiani D. Development of chronic myeloid leukemia in a patient with multiple myeloma: a case report. Haematologica. 2007;92:183.
  18. Dinçol G, Nalçaci M, Doğan O, Aktan M, Küçükkaya R, Ağan M, Dinçol K. Coexistence of chronic neutrophilic leukemia with multiple myeloma. Leuk Lymphoma. 2002;43(3):649-651.
  19. Badelita S, Dobrea C, Colita A, Dogaru M, Dragomir M, Jardan C, Coriu D. The simultaneous occurrence of multiple myeloma and JAK2 positive myeloproliferative neoplasms. Report on two cases. J Med Life. 2015;8(1):55-61.
  20. Breitkopf SB, Yuan M, Pihan GA, Asara JM. Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). Proc Natl Acad Sci USA. 2012;109(40):16190-16195.
  21. Ranni NS, Slavutsky I, Wechsler A, deSalum SB. Chromosome findings in multiplemyeloma. Cancer Genet Cytogenet. 1987;25(2):309-316.
  22. Martiat P, Mecucci C, Nizet Y, Stul M, Philippe M, Cassiman JJ, Michaux JL, VandenBerghe H, Sokal G. P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma. Leukemia. 1990;4(11):751-754.
  23. Diaz-Blanco E, Bruns I, Neumann F et al. Molecular signature of CD34(+) hematopoietic stem and progenitor Hematology 2008 441 cells of patients with CML in chronic phase. Leukemia. 2007;21:494-504.
  24. Manola KN, Pantelidou D, Papaioannou M. Plasmablastic crisis of Philadelphia chromosome-positive chronic myeloid leukemia. Ann Hematol. 2010;89(6):641-642.
  25. Leif Bergsagel P, Marta Chesi V. Molecular classification and risk stratification of myeloma. Hematol Oncol. 2013;31(01):38-41.
  26. Knudson AG. Cancer genetics. Am J Med Genet. 2002;111(1):96-102.
  27. Gnerre P, Ottonello L, Montecucco F, Boero M, Dallegri F. Nephrotic syndrome in a patient with IgM myeloma with associated neutrophilia. Eur J Haematol. 2007;79(1):76-80.
  28. Sebasky MM, Gupta P, Filice GA. Elevated granulocyte colony-stimulating factor, non-infectious leukocytosis and fevers in a patient with multiple myeloma. J Gen Intern Med. 2008;23(12):2134-2135.
  29. Malhotra J, Kremyanskaya M, Schorr E, Hoffman R. John Mascarenhas Clinical; Coexistence of Myeloproliferative Neoplasm and Plasma-Cell Dyscrasia. Lymphoma, Myeloma & Leukemia. 2014;14,1:31-36.
  30. Chang H, Shih LY. Concurrence of multiple myeloma and idiopathic erythrocytosis. Acta Clin Belg. 2009;64(5):434-435.
  31. Inase N, Shichiri M, Marumo F. Secondary polycythemia associated with multiple myeloma. Jpn J Med. 1989;28(3):396-398.
  32. Sykes DB, Schroyens W, O'Connell C. The TEMPI syndrome — a novel multisystem disease. New Eng J Med. 2011;365:475-477.
  33. Mohammadi F, Wolverson MK, Bastani B. А new case of TEMPI syndrome. Clin Kidney J. 2012;5(6):556-558.
  34. Rosado FG, Oliveira JL, Sohani AR, Schroyens W, Sykes DB, Kenderian SS, Lacy MQ, Kyle RA, Hoyer JD. Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist. Mod Pathol. 2015;28(3):367-372.
  35. Kwok M, Korde N, Landgren O. Bortezomib to treat the TEMPI syndrome. N Engl J Med. 2012;366:1843-1845.
  36. Bain BJ, Ahmad S. Chronic neutrophilic leukaemia and plasma cell-related neutrophilic leukaemoid reactions. Br J Haematol. 2015;171(3):400-410.Ка
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.